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ABSTRACT 
Background and Aims: A percentage of patients with irritable bowel syndrome (IBS)-like symptoms suffer 
from food hypersensitivity (FH) and improve on elimination diet. No assays have satisfactory sensitivity in 
identifying FH patients. The Aim of the study was to evaluate the frequency of FH diagnosis in IBS-like 
patients. To calculate sensitivity, specificity and diagnostic accuracy of fecal assays (tryptase, ECP and 
calprotectin) for FH diagnosis.  
Patients and Methods: 160 IBS patients were included. Elimination diet and double-blind placebo-controlled 
challenge were performed for FH diagnosis. Fecal assays and specific IgE were performed at the entry in the 
study.   
Results: 40 of 160 IBS patients (25%) suffered from FH.  Fecal ECP and tryptase values were significantly 
higher in FH than in IBS not-related to FH patients. ECP was the most accurate assay in FH diagnosis: 
sensitivity 65%, specificity 91%. 
Conclusions: A large percentage of IBS patients really suffer from FH. In these patients tryptase and ECP 
are among the pivotal mediators of the inflammation. Fecal assays of ECP can be useful in identifying FH 
patients among IBS-presenting subjects. 
 
 
 
 
 
 
 
